128 related articles for article (PubMed ID: 12763211)
1. Intrinsic variability in the detection of micrometastases in lymph nodes for re-staging of colorectal cancer. effect of individual markers and tissue samples.
Salto-Tellez M; Kong SL; Leong AP; Koay ES
Eur J Cancer; 2003 Jun; 39(9):1234-41. PubMed ID: 12763211
[TBL] [Abstract][Full Text] [Related]
2. Discordant quantitative detection of putative biomarkers in nodal micrometastases of colorectal cancer: biological and clinical implications.
Kong SL; Salto-Tellez M; Leong AP; Chan YH; Koay ES
J Clin Pathol; 2005 Aug; 58(8):839-44. PubMed ID: 16049286
[TBL] [Abstract][Full Text] [Related]
3. Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAS.
Oberg AN; Lindmark GE; Israelsson AC; Hammarström SG; Hammarström ML
Int J Cancer; 2004 Aug; 111(1):101-10. PubMed ID: 15185350
[TBL] [Abstract][Full Text] [Related]
4. Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20.
Futamura M; Takagi Y; Koumura H; Kida H; Tanemura H; Shimokawa K; Saji S
J Surg Oncol; 1998 May; 68(1):34-40. PubMed ID: 9610661
[TBL] [Abstract][Full Text] [Related]
5. Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.
Chen G; McIver CM; Texler M; Lloyd JM; Rieger N; Hewett PJ; Sen Wan D; Hardingham JE
Dis Colon Rectum; 2004 May; 47(5):679-86. PubMed ID: 15037935
[TBL] [Abstract][Full Text] [Related]
6. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
Bostick PJ; Chatterjee S; Chi DD; Huynh KT; Giuliano AE; Cote R; Hoon DS
J Clin Oncol; 1998 Aug; 16(8):2632-40. PubMed ID: 9704713
[TBL] [Abstract][Full Text] [Related]
7. Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer.
Waldman SA; Cagir B; Rakinic J; Fry RD; Goldstein SD; Isenberg G; Barber M; Biswas S; Minimo C; Palazzo J; Park PK; Weinberg D
Dis Colon Rectum; 1998 Mar; 41(3):310-5. PubMed ID: 9514425
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
[TBL] [Abstract][Full Text] [Related]
9. Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients.
Bustin SA; Siddiqi S; Ahmed S; Hands R; Dorudi S
Int J Cancer; 2004 Jan; 108(3):412-7. PubMed ID: 14648708
[TBL] [Abstract][Full Text] [Related]
10. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
Cagir B; Gelmann A; Park J; Fava T; Tankelevitch A; Bittner EW; Weaver EJ; Palazzo JP; Weinberg D; Fry RD; Waldman SA
Ann Intern Med; 1999 Dec; 131(11):805-12. PubMed ID: 10610624
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
12. [Detection of micrometastases of colorectal carcinoma in lymph nodes].
Roma A; Alvarez C; Paes de Lima A; Denninghoff V; Elsner B
Medicina (B Aires); 2003; 63(5):399-402. PubMed ID: 14628649
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.
Shimada R; Iinuma H; Akahane T; Horiuchi A; Watanabe T
Oncol Rep; 2012 Apr; 27(4):947-53. PubMed ID: 22267181
[TBL] [Abstract][Full Text] [Related]
14. Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer.
Rosenberg R; Hoos A; Mueller J; Nekarda H
Br J Cancer; 2000 Nov; 83(10):1323-9. PubMed ID: 11044357
[TBL] [Abstract][Full Text] [Related]
15. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.
Okami J; Dohno K; Sakon M; Iwao K; Yamada T; Yamamoto H; Fujiwara Y; Nagano H; Umeshita K; Matsuura N; Nakamori S; Monden M
Clin Cancer Res; 2000 Jun; 6(6):2326-32. PubMed ID: 10873083
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients.
Conzelmann M; Dieterle CP; Linnemann U; Berger MR
Int J Cancer; 2003 Nov; 107(4):617-28. PubMed ID: 14520701
[TBL] [Abstract][Full Text] [Related]
17. Detection of occult metastases in lymph nodes from patients with colorectal carcinoma by reverse transcriptase-polymerase chain reaction.
Liu Z; Ye X; Bi W; Wang M; Li Y; Chen T
Chin Med J (Engl); 2002 Apr; 115(4):529-31. PubMed ID: 12133290
[TBL] [Abstract][Full Text] [Related]
18. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction.
Mori M; Mimori K; Inoue H; Barnard GF; Tsuji K; Nanbara S; Ueo H; Akiyoshi T
Cancer Res; 1995 Aug; 55(15):3417-20. PubMed ID: 7542169
[TBL] [Abstract][Full Text] [Related]
19. Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry.
Noura S; Yamamoto H; Ohnishi T; Masuda N; Matsumoto T; Takayama O; Fukunaga H; Miyake Y; Ikenaga M; Ikeda M; Sekimoto M; Matsuura N; Monden M
J Clin Oncol; 2002 Oct; 20(20):4232-41. PubMed ID: 12377967
[TBL] [Abstract][Full Text] [Related]
20. Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker.
Nosotti M; Falleni M; Palleschi A; Pellegrini C; Alessi F; Bosari S; Santambrogio L
Chest; 2005 Sep; 128(3):1539-44. PubMed ID: 16162755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
